Sign In
Buy SPRO
$2.80
-0.0300 (-1.06%)
At Close: Jun 03, 2026
Are These Penny Stocks on Your September Buy List?
06:00am, Wednesday, 07'th Sep 2022
Here's what you need to know about buying penny stocks on September 7th The post Are These Penny Stocks on Your September Buy List? appeared first on Penny Stocks to Buy, Picks, News and Information |
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
05:36pm, Tuesday, 06'th Sep 2022 Benzinga
Gainers
HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partne
Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
12:05pm, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
Alignment with the FDA on a regulatory path forward for the continued development of tebipenem Hbr
Spero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
01:55pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
08:59am, Thursday, 18'th Aug 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced it plans to explore the potential development of a novel monkeypox vac
Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q2 2022 Results - Earnings Call Transcript
07:09pm, Thursday, 11'th Aug 2022
Spero Therapeutics, Inc. (NASDAQ:SPRO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Ted Jenkins - Vice President-Investor Relations & Strategic Finance Ankit Mahad
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
09:25pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update
08:05pm, Wednesday, 10'th Aug 2022 GlobeNewswire Inc.
Initiation of a Placebo-controlled Phase 2 Trial of SPR720 in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Expected in 4Q 2022
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
06:48pm, Wednesday, 10'th Aug 2022
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
12:05pm, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Wednesday, August 10, 2022
Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
08:05am, Tuesday, 09'th Aug 2022
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Wednesday, August 10, 2022 at
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
09:26am, Friday, 01'st Jul 2022 Benzinga
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Only one n
LiveOne And 24 Stocks Moving Premarket
10:32am, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 92.9% to $0.2295 in pre-market trading. Allena Pharmaceuticals said it previously entered into at market issuance sales agreement with B. Ril
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
08:25am, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application
08:05pm, Monday, 27'th Jun 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Adminis
